Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) Trading Down 2.4% – Here’s What Happened

Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT)’s share price dropped 2.4% on Thursday . The stock traded as low as $39.32 and last traded at $39.32. Approximately 2,233 shares were traded during trading, a decline of 67% from the average daily volume of 6,861 shares. The stock had previously closed at $40.30.

Innovator IBD Breakout Opportunities ETF Price Performance

The firm has a market cap of $13.76 million, a P/E ratio of 28.69 and a beta of 1.08. The stock’s 50 day moving average is $39.59 and its two-hundred day moving average is $38.40.

Innovator IBD Breakout Opportunities ETF Dividend Announcement

The business also recently disclosed an annual dividend, which was paid on Friday, January 2nd. Stockholders of record on Wednesday, December 31st were paid a $0.1249 dividend. This represents a dividend yield of 34.0%. The ex-dividend date was Wednesday, December 31st.

Hedge Funds Weigh In On Innovator IBD Breakout Opportunities ETF

Hedge funds have recently modified their holdings of the stock. Susquehanna International Group LLP lifted its position in shares of Innovator IBD Breakout Opportunities ETF by 42.6% during the 3rd quarter. Susquehanna International Group LLP now owns 26,176 shares of the company’s stock worth $1,020,000 after buying an additional 7,817 shares during the period. Comprehensive Wealth Management LLC grew its position in Innovator IBD Breakout Opportunities ETF by 122.0% in the fourth quarter. Comprehensive Wealth Management LLC now owns 23,403 shares of the company’s stock valued at $850,000 after acquiring an additional 12,859 shares during the period. Finally, Osaic Holdings Inc. grew its position in Innovator IBD Breakout Opportunities ETF by 39.7% in the second quarter. Osaic Holdings Inc. now owns 2,102 shares of the company’s stock valued at $77,000 after acquiring an additional 597 shares during the period.

Innovator IBD Breakout Opportunities ETF Company Profile

The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is managed by Innovator.